Montelukast for sleep apnea: a review of the clinical effectiveness, cost effectiveness, and guidelines
CADTH
Record ID 32014000839
English
Authors' recommendations:
One study found that montelukast improved respiratory disturbances in children with mild to moderate obstructive sleep apnea (OSA). No published trials regarding the use of montelukast in adults with OSA were identified. No economic evaluations or evidence-based guidelines regarding the use of montelukast for the treatment of sleep apnea were identified.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.cadth.ca/media/pdf/htis/feb-2014/RC0515%20Montelukast%20for%20Sleep%20Apnea%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Sleep Apnea, Obstructive
- Acetates
- Quinolines
- Leukotriene Antagonists
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.